hyperacute-melanoma vaccine
Vaccineexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2006 (NCT00300612)
Timeline
Indications
Studied for
Mechanism of action
- Tumor antigensImmunity, active
Tumor antigens immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- hyperacute-melanoma vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02054520 | Phase 2 | Jun 1, 2014 | NewLink Genetics Inc |
| NCT00300612 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2006 | NewLink Genetics Inc, University of South Florida |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| NewLink Genetics Inc | For profit | 2 | 2 | 1 | 2006 |
| University of South Florida | Academic/Hospital | 1 | 0 | 1 | 2006 |
2 organizations
Page 1 / 1